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Abstract
Background: Breast cancer is more common in Western Countries compared to African populations. However in
African population, it appears that the disease tends to be more aggressive and occurring at a relatively young age at
the time of presentation. The aim of this study was to describe the trend of Breast Cancer in Northwestern Tanzania.
Methods: This was a retrospective study which involved all cases of breast cancer diagnosed histologically at
Bugando Medical Center from 2002 to 2010. Histological results and slides were retrieved from the records in the
Pathology department, clinical information and demographic data for patients were retrieved from surgical wards
and department of medical records. Histology slides were re-evaluated for the histological type, grade (By modified
Bloom-Richardson score), and presence of necrosis and skin involvement. Data was entered and analyzed by SPSS
computer software version 15.
Findings: There were 328 patients histologically confirmed to have breast cancer, the mean age at diagnosis was
48.7 years (+/- 13.1). About half of the patients (52.4%) were below 46 years of age, and this group of patients had
significantly higher tendency for lymph node metastasis (p = 0.012). The tumor size ranged from 1 cm to 18 cm in
diameter with average (mean) of 5.5 cm (+/- 2.5), and median size of 6 cm. Size of the tumor (above 6 cm in
diameter) and presence of necrosis within the tumor was significantly associated with high rate of lymph node
metastasis (p = 0.000). Of all patients, 64% were at clinical stage III (specifically IIIB) and 70.4% had lymph node
metastasis at the time of diagnosis. Only 4.3% of the patients were in clinical stage I at the time of diagnosis. Majority
of the patients had invasive ductal carcinoma (91.5%) followed by mucinous carcinoma (5.2%), Invasive lobular
carcinoma (3%) and in situ ductal carcinoma (0.3%). In all patients, 185 (56.4%) had tumor with histological grade 3.
Conclusion: Breast cancer in this region show a trend towards relative young age at diagnosis with advanced
stage at diagnosis and high rate of lymph node metastasis. Poor Referral system, lack of screening programs and
natural aggressive biological behavior of tumor may contribute to advanced disease at the time of diagnosis.
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Background
Breast cancer is a significant cause of mortality world-
wide, with a prevalence that is estimated to be 1,000,000
annually[1]. In African women, the diagnosis is often
made between 35 and 45 years of age. This is fifteen
years earlier than women in Europe and North America.
One study showed the mean age of diagnosis in black
patient was 57.6 years with large tumor size compared to
62.6 years in white patients. The overall incidence was
lower in black women although for patients younger than
40 years the incidence was higher by 20% in black
women[2]. The estimated age standardized rates for
breast cancer incidence in sub-Saharan Africa range from
15 to 53 per 100, 000 women, which is lower than what
is seen in Western countries[3]. The mortality rate tends
to be high among women in sub-Saharan Africa as
tumors tend to be very aggressive with short periods of
time between the onset of symptoms and diagnosis[4].
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female cancers in years 1974-1987, and most of the
patients were under 30 years of age[5]. A study done in
Dar-es-Salaam on 50 patients showed that most patients
presented with advanced stage with no single patient in
stage I, and the the majority were in stage IIIB[6]. In
other parts of the world older women are at high risk,
where approximately 77% of the breast cancer occurs in
women over 50 years[7], but this trend is somehow dif-
ferent in Africans where the disease is common at
young age[3]. In sub Saharan Africa, the disease is seen
commonly in women below 30 years of age[8].
Few studies have shown that breast cancer in Africans
tends to present at a young age with advanced aggres-
sive disease with a poor prognosis compared to Western
white females[4,9,10]. Furthermore, breast cancer in
Africa shows the trend of rapid increase[11].
Several factors have been implicated in the prognosis
of the patients with breast cancer. Age has been shown
to be an important factor in the prognosis of breast can-
cer, where by disease presentation at young age has
shown a worse prognosis than in older age[12]. This has
been explained by the fact that cancer at young age
tends to be more aggressive and biological behavior
could be different. In Africans, breast cancer tends to
present at young age and this could be a reasons for
bad prognosis in these patients [4,8-10].
The clinical stage of the disease at presentation is
important for the outcome of the patient with breast
cancer. In most African patients, especially at young
age, the disease present at an advanced stage [3,8]. This
can be explained by delay in seeking medical services,
poor medical service with no screening programs for
breast cancer. The staging of the patient in conjunction
with histological grade can be used to determine the
prognosis of the patient. Whereas stage I disease has
about 96% 5-year survival, this can be as low as 18% 5-
year survival rate in stage IV. By using histological grade
alone, histological grade I has about 93% 5-year survival.
Stage I disease with histological grade I has shown a
99% 5-year survival compared to only 13% 5-year survi-
val in stage IV with histological grade III[13-15]. Histo-
logical grade used is that described by Bloom &
Richardson[16].
One less common histological type of breast cancer
called centrally necrotizing carcinoma of the breast has
shown to be more aggressive by having early metastasis
and rapid clinical progression and it was found to be
good for determining prognosis in pre-menopausal
women [17,18]. This study was therefore, carried to
describe clinical and pathological features of patients
with breast cancer in this region and compare the
trends with other regions.
Methods
This was a retrospective study of histologically con-
firmed cases of breast cancer seen at the department of
Pathology of Bugando Medical Centre (BMC) over a
period of 9-years between January 2002 and September
2010. BMC is a consultant, tertiary care and teaching
hospital for the Weill-Bugando University Collage of
Health Sciences (WBHCHS) with a bed capacity of 870.
Subjects of this study included all histologically con-
firmed breast cancer made during the period of 2002 to
2010. Data was retrieved from the records in the Pathol-
ogy department. Histology slides were re-evaluated for
histological type; and grade was established by Modified
Bloom-Richardson score system which scores for tubu-
lar formation, nuclear pleomorphism and mitotic rate
within tumor cells. Other tumor morphological features
like presence of necrosis, and involvement of the skin
was evaluated. The clinical stage of the disease was
assigned to each patient by using TNM (AJCC cancer
staging manual); this is a staging system which is
expression of anatomical extent of disease based on
extent of primary tumor (T), absence or presence of and
extent of regional lymph node metastasis (N) and
absence or presence of distant metastasis. The clinical
information and demographic information was obtained
from Patients’ files kept in the Medical record depart-
ment and the surgical wards. Patients with incomplete
data were excluded from the study. Ethical approval to
conduct the study was obtained from the WBUCHS/
BMC joint institutional ethic review committee before
the commencement of the study. Data were entered and
analyzed using SPSS computer software version 15.
Being a retrospective study, it was not possible to estab-
lish exact time period of theo n s e to ft h ed i s e a s e ,a n d
follow up of the patients was not possible and survival
could not be established. By doing prospective study the
patients can be properly followed and patient’ss u r v i v a l
and prognostic factors can be established.
Results
In this study there were 328 patients with histologically
confirmed breast cancer, the mean age at diagnosis was
47.8 (+/- 13) and the median was 46 years. 30.2% of the
patients were in age group of 30 - 40 years, followed by
41-50 years (25.9%), and age group below 30 years were
21% and only 17.4% were above 60 years (Table 1). The
tumor size ranged from 1 cm to 18 cm in diameter with
average (mean) of 5.5 cm (+/- 2.5). Majority of the
patients (64%) were at clinical stage III, and 70.4% of
the patients had lymph node metastasis at the time of
diagnosis (Table 1)
Of all patients, 91.5% (300) had invasive ductal carci-
noma, 3% (10) has Invasive lobular carcinoma and 5.2%
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Page 2 of 6(17) had mucinous carcinoma (Figure 1), [Figure 2] and
[Figure 3], only one patient had in situ ductal carci-
noma. 56.4% (185) of the patients had histological grade
3, 42.1%(138) grade 2 and 1.5% (5) grade 1.
Tumor size was significantly associated with rate of
lymph node metastasis. Patients with tumors above 6
cm which was the median size, had high rate of lymph
node metastasis compared to patients with tumor below
6 cm [p = 0.000] (Table 2).
Patients below 46 years of age (median age) also had
high rate of lymph node metastasis compared to the
patients above median age (p = 0.012) (Table 3). Pre-
sence of necrosis within the tumor was significantly
found in tumors above 6 cm [p = 0.000] (Table 4) and
such tumors were commonly seen in patients below 46
years of age [p = 0.012] (Table 5), however the presence
of necrosis within the tumor was not associated with
rate of lymph node metastasis (p = 0.205).
Tumors with low histological grade had low rate of
lymph node metastasis compared to high grade tumors,
statistical association was not established because only 5
patients (1.6%) had low grade tumors. All grade one
tumors were below 6 cm in diameter, 58% of grade two
were below 6 cm, and 47.6% of grade three tumors were
below 6 cm, there was a trend of high grade tumors to
be of larger size though association could not be estab-
lished. Ulcerated tumors were commonly seen in grade
three tumors, and high grade tumors were also common
in patients with less than 46 years of age.
Table 1 Patients age profile, clinical stage and lymph
Node metastasis at the time of diagnosis
Age group (years) N (%)
Below 30 21(6.4)
30-40 99(30.2)
41-50 85(25.9)
51-60 66(20.1)
Above 60 57(17.4)
Stage at the time of diagnosis
O 1 (0.3)
I 14 (4.3)
II 68 (20.7)
III 210(64.0)
IV 35 (10.7)
Lymph node metastasis
Positive 231 (70.4)
Negative 97 (29.6)
Total 328
Figure 1 Photomicrograph of Invasive ductal carcinoma of the
breast grade 2, H and E stain (×10).
Figure 2 Photomicrograph of Invasive lobular carcinoma of the
breast with Typical Indian file pattern of Infiltration, H and E
stain (×20).
Figure 3 Photomicrograph of mucinous carcinoma of the
breast, a cluster of tumor cells in a pool of mucin, H and E
stain (×20).
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Page 3 of 6Managements of those patients included mastectomy
with axillary lymph node clearance followed by adjuvant
hormonal therapy or chemotherapy. A patient with
advanced disease, down staging of the tumor was done
by radiation followed by surgery. Radiation and che-
motherapy was used as palliative care for patients with
advanced inoperable disease.
Discussion
In this study the mean age at diagnosis was 47.8 years,
T h ef i n d i n g sa r et h es a m ea st h a ts e e ni nG h a n aw h e r e
the mean age at diagnosis was 48 years[19]. Our finding
shows that 17.4% of patients were above 60 years of age,
which is the mean age of diagnosis in African American
(60.8 years) and in white Americans (62.4 years). It has
been reported that the occurrence of breast cancer at
young age is associated with a worst prognosis and thus
prognosis improves with age, with the best prognosis in
patients over 75 years [20]. Similar findings were also
seen in Nigeria and Senegal where the mean age at diag-
nosis was 44.8, with majority of tumors being of high
grade, associated with advanced age and lymph node
involvement [21]. In our study, 70.4% had lymph node
involvement at the time of diagnosis while 64% were in
stage III (specifically IIB) which is advanced disease. In
addition the mean tumor size was larger (5.5 +/- 2.5)
compared to that seen in Nigeria and Senegal (4.4 +/-
2.0 cm) and histological high grade tumors were 56.4%
w h i c hi sr e l a t i v e l yl o w e r .As t u d yi nU g a n d aw h i c hi s
neighboring country reported the median age at diagno-
sis to be 45 years with peak age group of 30-39 years
[22], This trend is the same as seen in this study. Simi-
larly the study in British black women showed the med-
ian age at diagnosis was 46 years as seen in this study,
and these patients had also aggressive disease with more
of histology grade 3, high rate of lymph node metastasis;
and majority had triple negative tumors with basal like
features[23]. There is a high possibility that our patients
might have a lot of triple negative, this is an area which
need further investigation. Many studies showed that as
the age increases the tumors tends to be less aggressive
with low rate of lymph node metastasis, low clinical stage
and high levels of ER and PR expression. In younger
patients, the tumors tend to be of unfavorable histologi-
cal features with low receptor status [24]. Another study
showed the age of 80 years and above to have more
favorable histological features[25], this findings are also
seen in our study where patients below 46 years of age
had high rate of lymph node metastasis (p = 0.012)
In this study the tumor size was significantly asso-
ciated with presence of necrosis within the tumor and
rate of lymph node metastasis. Also large tumors were
seen to be of high histological grade although associa-
tion could not be established due to few numbers of
patients in grade one. In this study, large tumor size was
associated with younger age (below 46 years), and this
could explain the reasons for aggressive disease at
younger age. One study showed tumor with necrosis
and ER-/PR-were good predictors of metastasis in the
lungs[26], and observation from this study showed
majority of patients who had metastasis presents with
chest symptoms, and with this age profile and histologi-
cal features there is like hood that majority of our
patients are ER-/PR-. Similarly a study in Nigeria
showed statistically significant difference in the extent of
necrosis in the tumors of postmenopausal and premeno-
pausal patients. Lymph node-positive tumors had more
necrosis than lymph node-negative tumors[27]. In this
study Necrosis was not associated with lymph node
metastasis. Some studies had demonstrated that necrosis
is linked to poor prognosis; and necrosis was a feature
Table 2 Tumor size in association with lymph node
metastasis
Lymph node positive
N (%)
Total p-value
Tumor size
Below 6 cm 100 (57.8) 173
Above 6 cm 131 (84.5) 155 0.000
Total 231 328
Table 3 Patient age in association with Lymph node
metastasis
Age group (years) Lymph node positive
N (%)
Total p-value
Less than/equal 46 130 (75.5) 172
Above46 101 (64.7) 156 0.012
Total 231 328
Table 4 Tumor size in association with necrosis
Tumor size (cm) Presence of necrosis
N (%)
Total p-value
Below 6 59 (34) 173
Above 6 86 (55.4) 155 0.000
Total 145 328
Table 5 Tumor size in association with patient’s age
Age less/equal 45
yrs
Age above 45
yrs
Total p-
value
Tumor size
(cm)
Below 6 80 93 173
Above 6 92 63 155 0.012
Total 172 156 328
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Page 4 of 6of tumors possessing an aggressive phenotype (high
tumor grade), large size tumor and low estrogen recep-
tor status[28]. In this study necrosis was seen frequently
in high grade tumors than low grade tumors, however
due to few patients with grade I the statistical difference
could not be validated.
Ductal carcinoma was the commonest histological
type, which is similar to what is known in literature
[29]. In this study 5.2% (17) were mucinous tumors, this
was the second to infiltrating ductal carcinoma, and 10
patients out of 17 were above 46 years of age. The med-
ian age of patients with mucinous tumors was 55 years,
this is relatively younger compared to other studies,
however one study showed this tumors to occur at
mean age of 55 years, while another study showed mean
age was 53 [30,31]. Both studies showed that Mucinous
tumor had tendency to have better prognosis, low recur-
r e n c er a t ea n dl o wr a t eo fl y m p hn o d em e t a s t a s i s .
Lymph node metastasis in mucinous tumor is com-
monly associated with large tumors as seen in one study
(means size of 2.7 cm) [32], the high rate of lymph node
metastasis seen in our patients could be accounted for
by the large tumor size at the time of diagnosis.
Conclusion
T h i ss t u d ys h o w e dr e l a t i v e l yy o u n ga g ep r o f i l eo f
patients with breast cancer in this region, with high rate
of lymph node metastasis and advanced clinical stage at
the time of diagnosis. This study didn’t able to establish
exact time onset of the disease and its progress, which
needs further investigation. Poor Referral system, natural
aggressive biological behavior of tumor may contribute
to advanced disease at the time of diagnosis. Raising the
public awareness and introduction of screening method
can reduce mortality from breast cancer in this
community.
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